| 000 | 01887 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517073323.0 | ||
| 264 | 0 | _c20160606 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1432-0851 | ||
| 024 | 7 |
_a10.1007/s00262-015-1784-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSaraswathula, Anirudh | |
| 245 | 0 | 0 |
_aSerum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy. _h[electronic resource] |
| 260 |
_bCancer immunology, immunotherapy : CII _cFeb 2016 |
||
| 300 |
_a205-11 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 |
_aAntibodies _xblood |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xpharmacology |
| 650 | 0 | 4 |
_aB-Cell Activating Factor _xblood |
| 650 | 0 | 4 |
_aB-Lymphocytes, Regulatory _ximmunology |
| 650 | 0 | 4 |
_aCancer Vaccines _xadministration & dosage |
| 650 | 0 | 4 |
_aDacarbazine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aGlioblastoma _xblood |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunotherapy _xmethods |
| 650 | 0 | 4 |
_aInterleukin-10 _xmetabolism |
| 650 | 0 | 4 |
_aLymphocyte Activation _ximmunology |
| 650 | 0 | 4 | _aLymphocyte Count |
| 650 | 0 | 4 | _aTemozolomide |
| 650 | 0 | 4 |
_aVaccines, Subunit _xadministration & dosage |
| 700 | 1 | _aReap, Elizabeth A | |
| 700 | 1 | _aChoi, Bryan D | |
| 700 | 1 | _aSchmittling, Robert J | |
| 700 | 1 | _aNorberg, Pamela K | |
| 700 | 1 | _aSayour, Elias J | |
| 700 | 1 | _aHerndon, James E | |
| 700 | 1 | _aHealy, Patrick | |
| 700 | 1 | _aCongdon, Kendra L | |
| 700 | 1 | _aArcher, Gerald E | |
| 700 | 1 | _aSanchez-Perez, Luis | |
| 700 | 1 | _aSampson, John H | |
| 773 | 0 |
_tCancer immunology, immunotherapy : CII _gvol. 65 _gno. 2 _gp. 205-11 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00262-015-1784-3 _zAvailable from publisher's website |
| 999 |
_c25623755 _d25623755 |
||